Untreated, HER2 negative unresectable locally advanced or metastatic G/GEJ adenocarcinoma. 77.7% male, 45.2% with age ≥ 65 years, 23.3% ECOG 0, all patients were from China. The gene discussed is ERBB2; the disease is gastroesophageal junction adenocarcinoma.